TFRC and non-small cell lung carcinoma: Silencing TFR1 diminishes the elevated iron levels induced by trabectedin and significantly reduces cell death in NSCLC, underscoring the crucial role of TFR1 in mediating ferroptosis triggered by trabectedin [70].